The silent human chain event, which was organised by Cape Town Intifada and Deep South For Palestine, was set to take place ...

The Food and Drug Administration said it is granting petitions to allow galdieria extract blue, a blue color derived from ...

The FDA says that over the next 3–5 years it aims “to make animal studies the exception rather than the norm” for preclinical safety testing, starting with monoclonal antibodies and ...

The U.S. FDA has approved SELARSDI (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...

Exclusive-US FDA Asks Some Fired Pharma User Fee Negotiation Staff to Return By Patrick Wingrove (Reuters) -The U.S. Food and Drug Administration is asking some of its recently fired staff ...

(RTTNews) - May has just begun, and it's time to turn our attention to the FDA decisions on deck for the coming weeks. So far this year, the U.S. regulatory agency has approved only nine novel ...

(RTTNews) - Satsuma Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration has approved a 505(b)(2) New Drug Application (NDA) for Atzumi(dihydroergotamine (DHE)) nasal powder ...

Health care giantJohnson & Johnson said on Wednesday the US Food and Drug Administration (FDA) has approved its drug to treat patients aged 12 years and older with an immune-mediated disorder.

LITTLE ROCK, Ark. (KATV) — The FDA's decision to phase out petroleum-based synthetic food dyes is something many health-concerned parents are touting as a win. Here in Arkansas, moms on Facebook ...

An urgent recall has been issued for a bread brand sold throughout the U.S. that could contain “glass fragments,” according to an alert from the US Food and Drug Administration (FDA).

Kennedy Jr.'s layoffs. Kennedy initially planned to cut 3,500 employees from the FDA. In team-wide meetings that started last week, multiple FDA employees said they were informed by their ...

A lawsuit seeking to expose how the FDA unlawfully approved and pushed this dangerous drug was cut short, with the Supreme Court ruling in June 2024 that the plaintiffs lacked legal standing.